COMMITTEES
ISV Committee Structure

Awards/Prizes
Committee Purpose:
Dedicated to supporting the promise and professional development of Trainees in Vaccinology.
- Raise funding (via grant applications & donations for Awards)
- Responsible for reviewing applications to assist with travel expenses for Trainees to participate in ISV congresses.
- Recognize research achievements of Trainees via presenter prizes.
Dedicated to identifying and recommending outstanding ISV members for a variety of awards and honours.

Jean Boyer
Agenta Therapeutics Inc
(Chair)

Annaliesa Anderson
Pfizer

Erica Anderson-Nissen
Cape Town HVTN Immunology Laboratory

Barbara Felber
National Cancer Institute(NCI), USA

Ebony Gary
The Wistar Institute

Sarah Gilbert
University of Oxford, United Kingdom

Linda Klavinskis
King’s College London

Margaret Liu
ProTherImmune and Karolinska Institute

Waranyoo Phoolcharoen
Chulalongkorn University

Ed Rybicki
University of Cape Town

David Weiner
Wistar Institute
Finance & Governance
Committee Purpose:
Dedicated to providing advice for best financial practices and governance, in line with the ISV Constitution.
- Review ISV annual Congress-related expenses and contracts
- Review annual financial activities and tax declaration of ISV
- Propose codes of conduct to help ascertain the accomplishment of ISV’s mission and values

Lakshmi Krishnan
National Research Council, Canada (NRC)
(Chair)

Linda Klavinskis
King’s College London

Margaret Liu
ProTherImmune and Karolinska Institute

Lenny Moise
Seromyx

Jeffrey Ulmer
TechImmune
Audit Subcommittee

Lakshmi Krishnan
National Research Council, Canada

Margaret Liu
ProTherImmune and Karolinska Institute
Global Collaboration and Partnerships
Committee Purpose:
Dedicated to uniting the global community of vaccinologists
- Engage and partner with vaccine groups globally.
- Promote communication and collaboration among organizations who seek to innovate, develop, manufacture, and enhance vaccines.
- Promote the development and use of vaccines to prevent and control infectious and non-infectious diseases in animals and humans.
- Engage ISV Fellows to build and promote ISV.

Shan Lu
Worcester HIV Vaccine (Chair)

Alexander Bukreyev
The University of Texas Medical Branch at Galveston

Denise Doolan
University of Queensland

Davinder Gill
StiRx Inc

Kopek Nihlmark
Karolinska Institute

Ed Lavelle
Trinity College Dublin
Mentorship
Committee Purpose:
The ISV Mentorship Committee exists to guide and support a strong mentorship program that connects mentors and mentees for personal and professional development of mentees by facilitating structured, effective, and meaningful mentorship relationships. The committee oversees the implementation, evaluation, and improvement of the mentorship program, and ongoing support of all mentorship activities.
This will be achieved by:
- Matching mentors and mentees based on interests, goals, and expertise.
- Building a culture of continuous learning and collaboration through mentorship.
- Ensuring meaningful connections between mentors and mentees.
- Providing resources, training, and support to mentors and mentees throughout the mentorship period.
- Gathering feedback and improve the program over time

Linda Lua (Chair)
Professor Emeritus,
The University of Queensland and
The Growth Impact Pty Ltd, Australia

Neil Almond
MHRA (NIBSC), United Kingdom

Sandra Depelsenaire,
Vaxxas, Australia

Barbara Felber
National Cancer Institute(NCI), USA

Michael Schotsaert
Ichan School of Medicine, Mount Sinai, Belgium
Outreach and Public Engagement
Committee Purpose:
Dedicated to promoting vaccine awareness and education, community engagement and participation. We serve as a bridge between science, policy, and the public.
- Active presence in social media platforms
- Organizing global webinar series
- Bi-monthly newsletters
- Responsible for paper of the month (POM) where a scientific paper is recognized by the society.
- Responsible for paper of the year (POY) where the most impactful vaccine related scientific paper is recognized by the society.
- Interviews with healthcare professionals and policymakers
- Highlighting vaccine related topics for both professionals and the public

Lars Frelin
Karolinska Institute (Chair)

Sita Awasthi
University of Pennsylvania

Martin Beukema
University of Groningen

Alejandra Capozzo
Universidad Abierta Interamericana, Buenos Aires

Ebony Gary
The Wistar Institute
(ISV Newsletter Editor )

Davinder Gill
StiRx Inc

Branka Grubor
University of Adelaide

Ted Ross
Cleveland Clinic

Ed Rybicki
University of Cape Town
Paper of the Month Sub-Committee
Sub-Committee Purpose:
Members of the Paper of the Month group scan through peer reviewed scientific papers on Vaccines and Immunotherapeutics each month and select a paper that highlights important developments in the vaccine field that will be of interest to the global ISV community and beyond.

Sita Awasthi
University of Pennsylvania

Alexander Bukreyev
The University of Texas Medical Branch at Galveston

Lars Frelin
Karolinska Institute,

Nisha Garg, Ph.D
University of Texas Medical Branch

Céline Lemoine
Vaccine Formulation Institute

Ajit Singh, PhD
Sanskaram University College of Veterinary & Animal Sciences

Marija Zaric
IAVI, UK
ISV Scientific Webinar Steering Sub-Committee
Committee Purpose:
The Steering Committee provides strategic oversight to ensure the quality, relevance, and impact of our webinar series.
Composed of experts from diverse fields, the committee selects timely topics, recommends qualified speakers, and upholds scientific integrity.
Its goal is to deliver engaging, evidence-based content that not only supports professional development but also fosters meaningful dialogue within the vaccine and healthcare community.
By choosing topics that are both engaging and informative, the committee makes sure the webinars are an important resource for learning and professional growth.

Ted Ross
Cleveland Clinic
(Chair)

Sita Awasthi
University of Pennsylvania

Lars Frelin
Karolinska Institute

Linda Klavinskis
King’s College London

Albert Osterhaus
University of Veterinary Medicine Hannover (TiHo), Germany
Vaccine Industry Interaction
Committee Purpose:
Dedicated to developing a donation and sponsorship program to ensure sustainability of our society.
- Develop partnership packages for various stakeholders.
- Ensure active industry participation in our programming.
- Support initiatives valued by our stakeholders.

Danilo Casimiro
Sanofi (Chair)

Manon Cox
NextWaveBio

Ravi Degun
EY-Parthenon

Corey Fang, Pharm.D.
AstraZeneca

Linda Klavinskis
King’s College London

Shan Lu
Worcester HIV Vaccine

Jeffrey Ulmer
TechImmune

David Weiner
Wistar Institute

Xuefei Zhou
Founder and Principal, XZ GMP Consulting, LLC
Board Nominations Committee
The Committee Purpose:
- Solicit and encourage recommendations of qualified individuals for nomination to the ISV Board of Directors.
- Review all nominations to ensure that candidates possess the expertise, experience, and commitment necessary to contribute effectively to the Board’s mission.
- Promote a diverse and inclusive leadership by ensuring representation in the vaccine sciences across human and animal health, encompassing basic research and clinical development, from academia, industry, government, NGOs, from geographic regions, career stages, and other dimensions of diversity relevant to the ISV’s global community.

Linda Klavinskis
King’s College London, UK
(Chair)

Peter Lawaetz Andersen
Novo Nordisk Foundation, Denmark

Manon Cox
NextWaveBio, USA

Barbar Felber
National Cancer Institute (NCI), USA

Jerome Kim
International Vaccine Institute, South Korea
